Norway -
Norway -
Statens legemiddelverk
pamidronatdinatrium pfizer 6 mg/ ml
pfizer as - dinatriumpamidronat - konsentrat til infusjonsvæske - 6 mg/ ml
Norway -
Norway -
Statens legemiddelverk
septocaine 40 mg/ ml / 5 mikrog/ ml
septodont - artikainhydroklorid / adrenalintartrat - injeksjonsvæske, oppløsning - 40 mg/ ml / 5 mikrog/ ml
Norway -
Norway -
Statens legemiddelverk
septocaine forte 40 mg/ ml / 10 mikrog/ ml
septodont - artikainhydroklorid / adrenalintartrat - injeksjonsvæske, oppløsning - 40 mg/ ml / 10 mikrog/ ml
Norway -
Norway -
Statens legemiddelverk
topimax 15 mg
janssen-cilag as - topiramat - kapsel, hard - 15 mg
Norway -
Norway -
Statens legemiddelverk
topimax 25 mg
janssen-cilag as - topiramat - kapsel, hard - 25 mg
Norway -
Norway -
Statens legemiddelverk
topimax 25 mg
janssen-cilag as - topiramat - tablett, filmdrasjert - 25 mg
Norway -
Norway -
Statens legemiddelverk
topimax 50 mg
janssen-cilag as - topiramat - tablett, filmdrasjert - 50 mg
Norway -
Norway -
Statens legemiddelverk
topimax 100 mg
janssen-cilag as - topiramat - tablett, filmdrasjert - 100 mg
Norway -
Norway -
Statens legemiddelverk
topimax 200 mg
janssen-cilag as - topiramat - tablett, filmdrasjert - 200 mg
Kesatuan Eropah -
Norway -
EMA (European Medicines Agency)
tavneos
vifor fresenius medical care renal pharma france - avacopan - microscopic polyangiitis; wegener granulomatosis - immunsuppressive - tavneos, in combination with a rituximab or cyclophosphamide regimen, is indicated for the treatment of adult patients with severe, active granulomatosis with polyangiitis (gpa) or microscopic polyangiitis (mpa).